FDA Center for Drug Evaluation & Research Issues Warning Letter to Chemco
April 15, 2026
April 15, 2026
WASHINGTON, April 15 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Chemco Corp. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Eitelberg G. Montarroyos, Sr., Chief Executive Officer, Chemco Corporation, 4920 NW 165th Street, Miami Lakes, FL 33014-6323, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warni . . .
* * *
Recipient: Mr. Eitelberg G. Montarroyos, Sr., Chief Executive Officer, Chemco Corporation, 4920 NW 165th Street, Miami Lakes, FL 33014-6323, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warni . . .